Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing

Ovarian cancer (OC) is the leading cause of death from gynecological malignancies. Despite great advances in treatment strategies, therapeutic resistance and the gap between preclinical data and actual clinical efficacy justify the necessity of developing novel models for investigating OC. Organoids...

Descripción completa

Detalles Bibliográficos
Autores principales: Psilopatis, Iason, Sykaras, Alexandros G., Mandrakis, Georgios, Vrettou, Kleio, Theocharis, Stamatios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855526/
https://www.ncbi.nlm.nih.gov/pubmed/36672509
http://dx.doi.org/10.3390/biomedicines11010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855526/
https://www.ncbi.nlm.nih.gov/pubmed/36672509
http://dx.doi.org/10.3390/biomedicines11010001

Ejemplares similares